Status:
COMPLETED
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Eligibility Criteria
Inclusion
- Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
- Patient requires IOP-lowering drug in both eyes
Exclusion
- Uncontrolled medical conditions
- contraindication to beta-adrenoceptor antagonist or brimonidine therapy
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2001
Estimated Enrollment :
573 Patients enrolled
Trial Details
Trial ID
NCT00332384
Start Date
January 1 2000
End Date
November 1 2001
Last Update
May 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Newport Beach, California, United States